27/10/08
Launch of a ph.III clinical trial in adults for Oralair Grasses in the US
Operating income expected to remain stable in 2009
07/10/08
Partnership with Catalent and The Medical House
Partnership for commercialization of adrenaline autoinjector in Europe
06/10/08
Launch of Stallergenes Dutch internet website
The European bio-pharmaceutical company Stallergenes announces the launch...
| We comply with the HONcode standard for trustworthy health information: verify here. |
Last update: 05/11/2008
Stallergenes is an European biopharmaceutical laboratory specialising in the treatment by desensitisation of allergy-related respiratory conditions.
The Group's activities focus on research into allergy, and the development, production and distribution of allergen extracts for the curative treatment of allergic rhinitis and asthma.
Visit the investors website
